?>
Contact us
Follow Us
About Us
Members
Executive Director
Why Biosimilars
The Issue
Our Solutions
Biosimilars 101
Foundations
Core Principles
FDA Regulatory Tenets
Biosimilars FAQs
Future Evolution of Biosimilar Development
Approved Biosimilars
Advocacy
Our Action
Tools
News
Resources
Get Involved
Partners
News
Get more out of your business.
Reach it with Microsoft Dynamics 365 Business Central.
News
July 5, 2023
signalgroup
Biosimilars Forum Applauds Coherus for Launch of YUSIMRY™
News
June 30, 2023
signalgroup
Delivering on a Watershed Moment for Biosimilars and Patients
News
April 10, 2023
signalgroup
Biosimilars Key to Lowering Healthcare and Prescription Drug Costs, According to Employers
News
March 30, 2023
signalgroup
Biosimilars Forum Applauds the U.S. Senate Finance Committee for Holding PBMs Accountable for Prioritizing Profits over Patients
News
March 3, 2023
signalgroup
Biosimilars Forum Applauds Congressman Hudson for Supporting Biosimilars
Through Shared Savings Legislation
News
January 31, 2023
signalgroup
The Biosimilars Forum Calls on Decisionmakers to Deliver on Humira Biosimilars
News
November 10, 2022
signalgroup
Dorothy McCabe Member Spotlight
News
November 3, 2022
signalgroup
Biosimilars Forum Wins Global Biosimilars Industry Partner of the Year at Global Generics & Biosimilars Awards
News
October 4, 2022
signalgroup
Biosimilars Forum Applauds CMS Biosimilars Measure
News
October 4, 2022
signalgroup
Inflation Reduction Act – ASP+8 Biosimilars Payment Increase
Prev page
01
02
03
04
05
Next page